NCCS Starburst 250px

What Caught Our Eye: Costs of Care in a For-Profit System; New ACA Reporting; Precision Medicine; PSA Testing; End of Life Care

/in , , , , , , , , /by
What Caught Our Eye (WCOE), April 14, 2017
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

In the Spotlight

Published this week, Elisabeth Rosenthal’s An American Sickness: How Healthcare became Big Business and How You Can Take it Back describes the business of health care and how it fails patients. See her interview with Terry Gross on Fresh Air, as well as her tips for consumers to avoid unnecessary costs.

“How U.S. Health Care Became Big Business”


“Headed to the doctor? Ask these 6 questions to avoid unnecessary bills.”


Affordable Care Act

“Trump dangles Obamacare payments to force Dems to the table”

Via Politico — “Major health care and business groups — including the Chamber of Commerce, one of the Obamacare’s harshest critics — are growing increasingly anxious over the fate of the subsidy program. In a Wednesday letter, a broad coalition warned of a potential calamity if Trump doesn’t immediately rescue the subsidies.”

“Obamacare ‘Death Spirals’ Aren’t Going to Happen”

Via Fortune — “President Donald Trump is fond of saying that he will simply let Obamacare ‘explode’ (or implode, then explode). But the health law’s marketplaces are actually becoming more stable and may even churn out profits for some participating health insurers by 2018, according to a new Standard & Poor’s report.”

“How GOP Voters Are Getting in the Way of a Medicaid Rollback”

Via The Atlantic — “Before the ACA expansion, Medicaid served few working adults. That made it easy for critics to disparage it as a welfare program for poor families often implicitly portrayed as non-white. Now Medicaid not only serves more working-class adults, but also provides a lifeline to those mostly white, lower-income, rural, and small-town communities beset by rising health challenges and contracting economic opportunity.”

Cancer Policy

“What Precision Medicine Can Learn from the NFL”

Via Forbes — “With the upcoming NFL draft, it hit us–rival franchises compete bitterly on the field every Sunday, yet have developed a structure that enables the entire enterprise to flourish, and profit. What if a similar philosophy could be brought to precision medicine, encouraging data sharing so that drug development and discovery are accelerated, while still allowing for competition and profit?”

“The federal panel that opposed prostate cancer screening just changed its mind”

Via The Washington Post — “This is not a recommendation that says men should go get screened. This is a complex decision. Some men will want to avoid the chance of dying of prostate cancer no matter what, while others, given the side effects, will not think the benefits are worth it,” said Dr. Kirsten Bibbins-Domingo, an internist at the University of California at San Francisco.

“Doctor: Why the new direction on prostate cancer screening”

Via CNN.com — “Hopefully, we will all embrace shared or informed decision-making. Some men who are concerned about prostate cancer will elect to be screened, and others who are less concerned will not; doctors should support either decision. Once diagnosed, hopefully patients and their physicians will not rush into treatment but explore and consider all reasonable options,” said Dr. Otis Brawley, Chief Medical Officer of the American Cancer Society.

Coping with Cancer

“At the End of Life, A Way to Go Gentle”

Via New York Times Well Blog — Our friend Dr. Susan Gubar discusses Dr. Jessica Zitter’s recent book, Extreme Measures: Finding a Better Path to the End of Life. Dr. Gubar writes, “In place of hope for recovery, Dr. Zitter emphasizes, ‘the miracle of time at home, of pain management, of improved quality of life. These are all concepts I’ve seen families embrace in place of survival – the only concept of hope previously imagined.”

More From “What Caught Our Eye” »

Follow us on Twitter: @CancerAdvocacy

Take Action

Make An Impact

We are relentless in improving the quality of care and life after a cancer diagnosis. Your support makes all the difference right now.

Make a Gift »

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

ACA Update | April 10, 2017: New GOP Proposal Would Undermine Pre-Existing Condition... ProtectOurCare 1024px ProtectOurCare 1024px ACA Update | April 14, 2017: Town Hall Headlines, Cost-Sharing Subsidies, the...